New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that in one study,
Ultra-low dose rituximab controls disease activity for most rheumatoid arthritis patients in new study
![](https://besthealthtale.com/wp-content/uploads/sites/10/2021/11/Ultra-low-dose-rituximab-controls-disease-activity-for-most-rheumatoid-arthritis-patients-in-new-study-900x480.jpg)
besthealthtale.com
Home ยป
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that in one study,
New research from Roswell Park Comprehensive Cancer Center has uncovered genetic factors other than human leukocyte antigen (HLA) compatibility that